BETA-2 RECEPTOR AGONIST - METABOLISM AND PHARMACOLOGY

被引：48
|
作者：
MCFADDEN, ER
机构：
[1] BRIGHAM & WOMENS HOSP,DEPT MED,PETER BENT BRIGHAM DIV,BOSTON,MA
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1981年 / 68卷 / 02期
关键词：
D O I：
10.1016/0091-6749(81)90164-0
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：91 / 97
页数：7
相关论文
共 50 条
  • [1] BETA-2 AGONIST BRONCHODILATORS
    ALEXANDER, MR
    HENDELES, L
    GUERNSEY, B
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1977, 11 (09): : 526 - 532
  • [2] Trends in beta-2 agonist therapy
    Potter, Paul
    ALLERGY & CLINICAL IMMUNOLOGY INTERNATIONAL-JOURNAL OF THE WORLD ALLERGY ORGANIZATION, 2007, 19 (04): : 155 - 158
  • [3] EFFECTS OF BETA-2 AGONIST ON HEPATIC GLYCOGEN-METABOLISM IN THE FETAL LAMB
    WARBURTON, D
    PARTON, L
    BUCKLEY, S
    COSICO, L
    SALUNA, T
    PEDIATRIC RESEARCH, 1988, 24 (03) : 330 - 332
  • [4] PHYSIOLOGY AND PHARMACOLOGY OF BETA-2 ADRENERGIC AGENTS
    REED, CE
    CHEST, 1978, 73 (06) : 914 - 918
  • [5] Beta-2 receptor agonist exposure in the uterus associated with subsequent risk of childhood asthma
    Ogawa, Kohei
    Tanaka, Satomi
    Yang Limin
    Arata, Naoko
    Sago, Haruhiko
    Yamamoto-Hanada, Kiwako
    Narita, Masami
    Ohya, Yukihiro
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2017, 28 (08) : 746 - 753
  • [6] The effects of beta-2 adrenergic agonist and antagonist on human bone metabolism: A randomized controlled trial
    Veldhuis-Vlug, A. G.
    Tanck, M. W.
    Limonard, E. J.
    Endert, E.
    Heijboer, A. C.
    Lips, P.
    Fliers, E.
    Bisschop, P. H.
    BONE, 2015, 71 : 196 - 200
  • [7] LONG ACTING BETA-2 AGONIST (LABA) IN CHILDREN
    Chang, Anne B.
    RESPIROLOGY, 2010, 15 : 16 - 16
  • [8] THE BETA-2 ADRENERGIC-RECEPTOR ANTAGONIST CGP-12177A DISPLAYS AGONIST PROPERTIES IN RAT-THYROID FOLLICULAR CELLS EXPRESSING THE HUMAN BETA-2 RECEPTOR
    TSUZAKI, S
    MOSES, AC
    CLINICAL RESEARCH, 1991, 39 (02): : A155 - A155
  • [9] HEMODYNAMIC-EFFECTS OF AN INHALED BETA-2 AGONIST
    CHAPMAN, KR
    SMITH, DL
    REBUCK, AS
    LEENEN, FHH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) : 762 - 767
  • [10] THE EFFECTS OF A BETA-2 AGONIST AND A NONSELECTIVE BETA ANTAGONIST ON THEOPHYLLINE CLEARANCE
    LOMBARDI, TP
    BERTINO, JS
    GOLDBERG, A
    MIDDLETON, E
    SLAUGHTER, RL
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (06): : 455 - 455
12345